Yes. Semaglutide Semaglutide is a GLP-1R agonist used to treat type 2 diabetes. It has been included in the Class B reimbursement category of medical insurance. Its unique mechanism of action can not only reduce blood sugar levels, but also reduce cardiovascular risk. and guide weight loss. Such medications may be an effective treatment option for many patients with diabetes.